MANUFACTURERS LIFE INSURANCE COMPANY, THE - C4 THERAPEUTICS INC ownership

C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 114 filers reported holding C4 THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
MANUFACTURERS LIFE INSURANCE COMPANY, THE ownership history of C4 THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$179,286
-30.2%
65,195
-20.3%
0.00%
Q1 2023$256,698
-45.8%
81,7510.0%0.00%
Q4 2022$473,320
-32.6%
81,751
-0.0%
0.00%
Q3 2022$702,468
+7.3%
81,787
-7.8%
0.00%
Q2 2022$654,582
-68.0%
88,689
+4.4%
0.00%
-100.0%
Q1 2022$2,048,154
+217.1%
84,966
+330.4%
0.00%
Q4 2021$646,000
-25.4%
19,742
+1.8%
0.00%
-100.0%
Q3 2021$866,000
+19.9%
19,390
+1.6%
0.00%0.0%
Q2 2021$722,000
+219.5%
19,082
+211.9%
0.00%
Q1 2021$226,000
+10.2%
6,118
-1.0%
0.00%
Q4 2020$205,0006,1800.00%
Other shareholders
C4 THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
COMMODORE CAPITAL LP 481,094$21,495,0005.67%
Soleus Capital Management, L.P. 750,633$33,538,0005.23%
Bain Capital Life Sciences Investors, LLC 1,642,209$73,374,0004.55%
RTW INVESTMENTS, LP 2,494,965$111,475,0001.68%
P.A.W. CAPITAL CORP 40,000$1,787,0001.59%
Perceptive Advisors 2,258,566$100,913,0001.47%
SPHERA FUNDS MANAGEMENT LTD. 381,774$17,058,0001.43%
CLOUGH CAPITAL PARTNERS L P 347,500$15,526,0000.94%
HighVista Strategies LLC 29,341$1,311,0000.87%
RA Capital Management 1,377,569$61,550,0000.85%
View complete list of C4 THERAPEUTICS INC shareholders